Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: ES1M06M6QH

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Programmed cell death 1 ligand 1 binding agent PubMed Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 2 D009369 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Hepatitis B, Chronic 2 D019694 ClinicalTrials
Biliary Tract Neoplasms 2 D001661 ClinicalTrials
Carcinoma, Hepatocellular 1 D006528 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298006
FDA SRS ES1M06M6QH